ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q4 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $549,000 | +19.3% | 3,443 | -1.6% | 0.06% | +22.0% |
| Q2 2021 | $460,000 | +6.7% | 3,498 | +4.5% | 0.05% | -21.9% |
| Q1 2021 | $431,000 | +1.2% | 3,346 | +31.1% | 0.06% | -15.8% |
| Q4 2020 | $426,000 | +55.5% | 2,552 | +43.6% | 0.08% | +33.3% |
| Q3 2020 | $274,000 | +9.2% | 1,777 | -0.7% | 0.06% | +5.6% |
| Q2 2020 | $251,000 | +20.7% | 1,789 | +15.5% | 0.05% | -1.8% |
| Q1 2020 | $208,000 | – | 1,549 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,797,745 | $265,886,000 | 19.06% |
| RA Capital Management | 4,914,955 | $726,922,000 | 14.16% |
| Sofinnova Investments, Inc. | 1,109,874 | $164,150,000 | 10.35% |
| Eventide Asset Management | 1,709,848 | $252,887,000 | 5.50% |
| Asymmetry Capital Management, L.P. | 47,599 | $7,040,000 | 5.39% |
| BERYLSON CAPITAL PARTNERS, LLC | 58,200 | $8,608,000 | 5.30% |
| Avoro Capital Advisors LLC | 1,750,000 | $258,825,000 | 5.12% |
| Eversept Partners, LP | 220,344 | $32,588,878 | 4.47% |
| Spyglass Capital Management LLC | 452,104 | $66,866,000 | 4.14% |
| Orbimed Advisors | 1,562,986 | $231,166,000 | 3.25% |